12 January 2017 (11:25 UTC-07 Tango 06) 23 Dey 1395/13 Rabi ‘ath-Thani 1438/15 Ji Chou 4714
“We found that taking PPIs increased the risk of hospitalization with infectious gastroenteritis by up to 70 percent because they significantly reduce the amount of acid made by stomach, which increases risk of infectious gastro….. The elderly and those with chronic bowel problems are most at risk.”- Yingxi Chen, researcher
“They’re getting away with murder! Pharma. Pharma has a lot of lobbies, a lot of lobbyists and a lot of power.”-Donald Trump, President Elect United States, 11 January 2017
A suppressed study by Australian National University (ANU) concluded that pharmaceutical industry antacid (heartburn) drugs actually weaken your digestive system to the point you get sick with stomach ‘flu’ (gastroenteritis).
The anti-acids are also known as Proton Pump Inhibitors (PPIs), they shutdown your stomach’s acid production, but the study found that your stomach acid was key to preventing you from getting sick to your stomach with infections.
The study was prompted by an increase in the Aussie working class missing more and more days of work due to stomach infections; now at 13-million ‘lost’ work days per year. At least 20-million PPI prescriptions are issued every year in Australia!
Here’s the rub: The study was released in October of 2016, but only now is being reported by the main stream news media (which gets most of its advertising revenues from the pharma industry).
“Conclusion. PPI use is associated with an increased risk of infectious gastroenteritis hospitalization with increasing risks among increasing doses. Clinicians should be aware of this potential association when considering PPI therapy, and use the lowest effective dose for patients with appropriate indications.”-Use of Proton Pump Inhibitors and the Risk of Hospitalization for Infectious Gastroenteritis,
There’s more reasons why Donald Trump said the pharma industry is “getting away with murder”, as this stomach infection study is not the only PPI study being suppressed by the pharma industry:
Northwestern University: HEARTBURN MEDICATIONS CAN INCREASE RISK FOR HIP FRACTURES IN POSTMENOPAUSAL WOMEN
DrugWatch: PPI Heartburn Drugs May Increase Stroke Risk